Evidence map›Paper›PMID 31682733›Full record

ArticleNeuro-oncology2019

Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?

Marijke B Coomans, Linda Dirven, Neil K Aaronson, Brigitta G Baumert, Martin Van Den Bent, Andrew Bottomley, Alba A Brandes, Olivier Chinot, Corneel Coens, Thierry Gorlia and 10 more

Registry-linked trialAbstract read
In one paragraph

Article in Neuro-oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04717739 (Use of TTFields in Germany in Routine Clinical Care Study PROgram - Daily Activity, Sleep and Neurocognitive Functioning in Newly Diagnosed Glioblastoma Patients Study), which is not on this map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04717739 unknown statusnot on this mapstarted 2021, after this paper: background citation

Use of TTFields in Germany in Routine Clinical Care Study PROgram - Daily Activity, Sleep and Neurocognitive Functioning in Newly Diagnosed Glioblastoma Patients Study

TypeobservationalSponsorNovoCure Ltd.Ran2021 to 2025Enrolled500ConditionsGlioblastomaArmsTTFields
3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Symptom network and latent profile analysis in patients after glioma surgery: a cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Perioperative symptom cluster characteristics and supportive care needs of sellar tumor patients: a cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Food chemistry: X · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Marijke B CoomansDepartment of Neurology, Leiden University Medical Center, Leiden, Netherlands.
Linda DirvenDepartment of Neurology, Leiden University Medical Center, Leiden, Netherlands.
Neil K AaronsonDivision of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, Netherlands.
Brigitta G BaumertDepartment of Radiation-Oncology, University Hospital Bonn, Bonn, Germany.
Martin Van Den Bentthe Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, Netherlands.
Andrew BottomleyQuality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Alba A BrandesDepartment of Medical Oncology, Local Health Unit Company-Institute of Hospitalization and Scientific Care (Azienda USL-IRCCS), Institute of Neurological Sciences, Bologna, Italy.
Olivier ChinotAix-Marseille University, Neurophysiopathology Institute, University Hospital Center Timone, Neuro-Oncology Service, Marseille, France.
Corneel CoensQuality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Thierry GorliaEuropean Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.
Ulrich HerrlingerDivision of Clinical Neurooncology, Department of Neurology, University of Bonn Medical Center, Bonn, Germany.
Florence Keime-GuibertPitié-Salpetrière Hospital Group, Paris, France.
Annika MalmströmDepartment of Advanced Home Care and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Francesca MartinelliQuality of Life Department, European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Roger StuppNorthwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.
Andrea TalacchiDepartment of Neurosciences, San Giovanni Addolorata Hospital, Rome, Italy.
Michael WellerDepartment of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.
Wolfgang WickNeurology Clinic and National Centre for Tumour Diseases, University Hospital Heidelberg, Heidelberg, Germany, and German Consortium of Translational Cancer Research, Clinical Cooperation Unit Neurooncology, German Cancer Research Center, Heidelberg, Germany.
Jaap C ReijneveldDepartment of Neurology and Brain Tumour Center Amsterdam, Amsterdam University Medical Center, Amsterdam, Netherlands.
Martin J B TaphoornDepartment of Neurology, Leiden University Medical Center, Leiden, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSymptom management in glioma patients remains challenging, as patients suffer from various concurrently occurring symptoms. This study aimed to identify symptom clusters and examine the association between these symptom clusters and patients' functioning.

methodsData of the CODAGLIO project was used, including individual patient data from previously published international randomized controlled trials (RCTs) in glioma patients. Symptom prevalence and level of functioning were assessed with European Organisation for Research and Treatment of Cancer (EORTC) quality of life QLQ-C30 and QLQ-BN20 self-report questionnaires. Associations between symptoms were examined with Spearman correlation coefficients and partial correlation networks. Hierarchical cluster analyses were performed to identify symptom clusters. Multivariable regression analyses were performed to determine independent associations between the symptom clusters and functioning, adjusted for possible confounders.

resultsIncluded in the analysis were 4307 newly diagnosed glioma patients from 11 RCTs who completed the EORTC questionnaires before randomization. Many patients (44%) suffered from 5-10 symptoms simultaneously. Four symptom clusters were identified: a motor cluster, a fatigue cluster, a pain cluster, and a gastrointestinal/seizures/bladder control cluster. Having symptoms in the motor cluster was associated with decreased (≥10 points difference) physical, role, and social functioning (betas ranged from -11.3 to -15.9, all P < 0.001), independent of other factors. Similarly, having symptoms in the fatigue cluster was found to negatively influence role functioning (beta of -12.3, P < 0.001), independent of other factors.

conclusionsTwo symptom clusters, the fatigue and motor cluster, were frequently affected in glioma patients and were found to independently have a negative association with certain aspects of patients' functioning as measured with a self-report questionnaire.

Indexed as

Global HealthMotor ActivityQuality of LifeSeverity of Illness IndexFatigueFemaleGliomaHealth Status IndicatorsHumansMaleMiddle AgedPainPalliative CareRandomized Controlled Trials as TopicSurveys and QuestionnairesSymptom AssessmentEORTC QLQ-C30gliomahealth-related quality of lifeQLQ-BN20symptomsymptom cluster

Identifiers

PMID31682733
PMCPMC6827824

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.